Evaluation of usefulness in diagnosing brain tumors using 11C-methionine PET/CT

Evaluation of usefulness in diagnosing brain tumors using 11C-methionine PET/CT - Evaluation of 11C-methionine PET/CT for brain tumors.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003386

Enrollment

100

Registered

2010-06-01

Start date

2010-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain tumor

Interventions

11C-methionine PET/CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following conditions.1. brain (including intra-axial) tumor or suspected recurrence after treatment. 2. Surgery is planned (for only initial) 3. Medically fits for surgery 4. Written informed consent obtained.

Exclusion criteria

Exclusion criteria: Patients who meet at least one of the following conditions. 1. brain tumor 2. Medically unfit for surgery or suegery not planned. 3. Informed consent not given.

Design outcomes

Primary

Measure	Time frame
Concordance with histological diagnosis from surgical specimen.	—

Countries

Japan

Contacts

Public ContactNaomi Morita

Tokushima University Hospital Clinical Trial Support Center

first-ec@clin.med.tokushima-u.ac.jp088-633-9294

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026